It holds great promise in MM based on its induction of cell death in MM cell lines and primary tumor samples, especially those with t (11, 14) translocation, in which an increased dependency upon BCL-2 for MM cell survival has been determined (105–107). The gene discussed is BCL2; the disease is Miyoshi myopathy.